Table 2.

The changes of SHAPS and MADRS anhedonia factor scores with treatment of vortioxetine.

Variables	Baseline (n = 95)	Week 2 (n = 92)				Week 8 (n = 79)
	M ± SD	M ± SD	Δbaseline (95% CI)	z	p	M ± SD	Δbaseline (95% CI)	z	p
SHAPS score	6.2 ± 3.8	5.2 ± 4.5	−1.0 (−1.7, −0.3)	−2.88	0.004*	3.3 ± 3.8	−2.9 (−3.7, −2.2)	−7.88	< 0.0001*
MADRS anhedonia factor	18.3 ± 3.7	14.5 ± 5.1	−3.8 (−4.9, −2.7)	−7.22	< 0.0001*	11.4 ± 6.1	−7.1 (−8.2, −5.9)	−11.90	< 0.0001*

^*Indicates significant differences from baseline.